KOSPI · Healthcare · ₩864B
₩14,430-0.55%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 24.2% · as of 26.10.26
Among 97 제약 peers
Quarterly Revenue Growth
“해외 신약 확장이 대웅의 다음 성장을 이끌고 있어요.”
In the company's words · 2026 2분기 filing